BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15703780)

  • 1. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
    Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
    Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
    Ghosh AK; Secreto CR; Knox TR; Ding W; Mukhopadhyay D; Kay NE
    Blood; 2010 Mar; 115(9):1755-64. PubMed ID: 20018914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis.
    Raikwar NS; Shibuya M; Thomas CP
    Am J Physiol Cell Physiol; 2018 Aug; 315(2):C214-C224. PubMed ID: 29719170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia.
    Mani R; Mao Y; Frissora FW; Chiang CL; Wang J; Zhao Y; Wu Y; Yu B; Yan R; Mo X; Yu L; Flynn J; Jones J; Andritsos L; Baskar S; Rader C; Phelps MA; Chen CS; Lee RJ; Byrd JC; Lee LJ; Muthusamy N
    Leukemia; 2015 Feb; 29(2):346-55. PubMed ID: 24947019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the NTSR2/TrkB oncogenic pathway in chronic lymphocytic leukemia.
    Ikhlef L; Yassine M; Chandouri B; Rivière L; Naves T; Dmytruk N; Gachard N; Jauberteau MO; Gallet PF
    Sci Rep; 2024 Mar; 14(1):6084. PubMed ID: 38480783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation mediated angiogenesis in chronic lymphocytic leukemia.
    Mitrović-Ajtić O; Živković E; Subotički T; Diklić M; Đikić D; Vukotić M; Dragojević T; Vuković V; Antić D; Čokić VP
    Ann Hematol; 2024 May; ():. PubMed ID: 38713255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT-1: a novel regulator of apoptosis.
    Stephanou A; Latchman DS
    Int J Exp Pathol; 2003 Dec; 84(6):239-44. PubMed ID: 14748743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and survival of B-chronic lymphocytic leukaemia cells.
    Söderberg O
    Med Oncol; 1998 Jul; 15(2):73-8. PubMed ID: 9789213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binucleated and cloverleaf-shaped nucleus in lymphocytes in CLL.
    Barros Pinto MP; Cabeçadas J
    Blood; 2024 Feb; 143(9):833. PubMed ID: 38421814
    [No Abstract]   [Full Text] [Related]  

  • 10. The Effects of Green Tea Catechins in Hematological Malignancies.
    Della Via FI; Alvarez MC; Basting RT; Saad STO
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways.
    Ribatti D; Tamma R; Annese T; d'Amati A; Ingravallo G; Specchia G
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway.
    Bauvois B; Pramil E; Jondreville L; Quiney C; Nguyen-Khac F; Susin SA
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33668421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia.
    K Bhanumathy K; Balagopal A; Vizeacoumar FS; Vizeacoumar FJ; Freywald A; Giambra V
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy.
    Yang PL; Liu LX; Li EM; Xu LY
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia.
    Bauvois B; Pramil E; Jondreville L; Chapiro E; Quiney C; Maloum K; Susin SA; Nguyen-Khac F
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways.
    Farooqi AA; Pinheiro M; Granja A; Farabegoli F; Reis S; Attar R; Sabitaliyevich UY; Xu B; Ahmad A
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression.
    Ma W; Zhang Y; Qi Y; Guo S
    Arch Med Sci; 2019 Sep; 15(5):1163-1175. PubMed ID: 31572461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.
    Roy S; Bag AK; Singh RK; Talmadge JE; Batra SK; Datta K
    Front Immunol; 2017; 8():1228. PubMed ID: 29067024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells.
    Al-Sanabra O; Duckworth AD; Glenn MA; Brown BR; Angelillo P; Lee K; Herbert J; Falciani F; Kalakonda N; Slupsky JR
    Sci Rep; 2017 Feb; 7():43228. PubMed ID: 28233872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.